Al Manhal Platform The session has been expired. Please reload the page Reload Please
wait... The file is being prepared Preview Mode If you would like full access to this publication …

Abstract PRAME (Preferentially Expressed Antigen in Melanoma) gene is located on
chromosome 22 (22q11. 22) and is expressed at low levels by normal adrenal, ovarian and …

Although the PRAME activity was first discovered in solid tumors, this gene is very frequently
expressed in oncohematological diseases. PRAME can be regarded as a reliable biomarker …

PRAME has been proposed as a useful marker for solid tumors and acute B-cell
malignancies. Several studies demonstrate expression in CLL. To further examine its B-cell …

Preferentially expressed antigen of melanoma (PRAME) is a tumor antigen expressed in
various malignant tumors including solid tumors and hemopoietic neoplasias but no or weak …

The preferentially expressed antigen in melanoma (PRAME) gene is aberrantly expressed
in chronic lymphoproliferative disorders (CLD). We produced and characterized an anti …

PRAME is expressed at low levels in normal testes and highly in solid tumor cells and
hematological malignancies. The purpose of this study was to investigate PRAME …

Preferentially expressed antigen of melanoma (PRAME) is a cancer-testis antigen (CTA)
belonging to the group of tumor associated antigens. Te PRAME gene expression is low or …

This study was aimed to detect the expression levels of preferentially expressed antigen of
melanoma (PRAME) gene in acute leukemia (AL) and to evaluate the clinical significance of …

The gene PRAME (preferentially expressed antigen of melanoma) was found to be
expressed at high levels in a large fraction of different tumors and adult leukemias. Since …